Home › Compare › AMIN vs MRK

AMIN vs MRK: Dividend Comparison 2026

AMIN yields 500000.00% · MRK yields 2.76%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 AMIN wins by $252475121624236192.00M in total portfolio value
10 years
AMIN
AMIN
● Live price
500000.00%
Share price
$0.00
Annual div
$2.00
5Y div CAGR
-50%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$252475121624236192.00M
Annual income
$179,970,099,914,313,700,000,000.00
Full AMIN calculator →
MRK
Merck & Co. Inc.
● Live price
2.76%
Share price
$120.31
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$56.8K
Annual income
$9,798.13
Full MRK calculator →

Portfolio growth — AMIN vs MRK

📍 AMIN pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodAMINMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, AMIN + MRK cover 0 of 12 months — good coverage

Jan
—
Feb
—
Mar
—
Apr
—
May
—
Jun
—
Jul
—
Aug
—
Sep
—
Oct
—
Nov
—
Dec
—
AMIN pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

AMIN
Annual income on $10K today (after 15% tax)
$42,500,000.00/yr
After 10yr DRIP, annual income (after tax)
$152,974,584,927,166,630,000,000.00/yr
MRK
Annual income on $10K today (after 15% tax)
$234.56/yr
After 10yr DRIP, annual income (after tax)
$8,328.41/yr
At 15% tax rate, AMIN beats the other by $152,974,584,927,166,630,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of AMIN + MRK for your $10,000?

AMIN: 50%MRK: 50%
100% MRK50/50100% AMIN
Portfolio after 10yr
$126237560812118096.00M
Annual income
$89,985,049,957,156,840,000,000.00/yr
Blended yield
71.28%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

AMIN
No analyst data
Altman Z
-6.4
Piotroski
3/9
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+6.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

AMIN buys
0
MRK buys
0
No recent congressional trades found for AMIN or MRK in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricAMINMRK
Forward yield500000.00% ✓2.76%
Annual dividend / share$2.00$3.32 ✓
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR-50%32.7% ✓
Portfolio after 10y$252475121624236192.00M ✓$56.8K
Annual income after 10y$179,970,099,914,313,700,000,000.00 ✓$9,798.13
Total dividends collected$246974404501167104.00M ✓$28.9K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: AMIN vs MRK ($10,000, DRIP)

YearAMIN PortfolioAMIN Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$25,010,700$25,000,000.00$11,206$366.19+$25.00M → AMIN
2$29,244,868,926$29,218,107,476.64$12,650$502.35+$29244.86M → AMIN
3$15,996,042,711,578$15,964,750,701,827.40$14,407$694.19+$15996042.70M → AMIN
4$4,097,595,673,237,753$4,080,479,907,536,365.00$16,585$967.82+$4097595673.22M → AMIN
5$492,827,571,123,448,100$488,443,143,753,083,800.00$19,342$1,363.89+$492827571123.43M → AMIN
6$27,978,829,179,189,830,000$27,451,503,678,087,737,000.00$22,913$1,947.19+$27978829179189.80M → AMIN
7$758,198,099,371,876,500,000$728,260,752,150,143,400,000.00$27,662$2,823.89+$758198099371876.50M → AMIN
8$10,033,296,784,320,553,000,000$9,222,024,817,992,646,000,000.00$34,159$4,173.35+$10033296784320554.00M → AMIN
9$67,761,702,532,637,870,000,000$57,026,074,973,414,870,000,000.00$43,337$6,308.80+$67761702532637872.00M → AMIN
10$252,475,121,624,236,200,000,000$179,970,099,914,313,700,000,000.00$56,776$9,798.13+$252475121624236192.00M → AMIN

AMIN vs MRK: Complete Analysis 2026

AMIN — Stock

American International Industries, Inc. holds interests in industrial, oil and gas, oilfield supply and service, and undeveloped real estate companies in the United States. The company supplies products to retailers and wholesalers in the automotive after-market and in the consumer durable electrical products markets under the Good Choice and MOTOR TREND brand names. Its MOTOR TREND branded products include booster cables, portable and rechargeable hand lamps, lighting products, cord sets, and miscellaneous battery and other consumer automotive accessories; and Good Choice branded products comprise portable lighting products, cord sets, residential household light bulbs, night lights, multiple outlet devices, and other consumer products. The company also provides owns oil and gas properties in Texas, as well as real estate holdings in Harris, Galveston, and Waller counties in Texas. American International Industries, Inc. was founded in 1994 and is based in Kemah, Texas.

Full AMIN Calculator →

MRK — Healthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this AMIN vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

AMIN vs SCHDAMIN vs JEPIAMIN vs OAMIN vs KOAMIN vs MAINAMIN vs JNJAMIN vs ABBVAMIN vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.